| 臺大學術典藏 |
2021-05-25T06:36:14Z |
Characterization of a factor IX variant with a glycine207 to glutamic acid mutation
|
Lin S.-W.; Lin C.-N.; Hamaguchi N.; Smith K.J.; MING-CHING SHEN |
| 臺大學術典藏 |
2021-05-25T06:36:06Z |
Engineered recombinant factor VII Q217 variants with altered inhibitor specificities
|
Chang Y.-J.; Hamaguchi N.; Chang S.-C.; Ruf W.; MING-CHING SHEN; Lin S.-W. |
| 臺大學術典藏 |
2021-05-25T06:36:05Z |
Hemophilia B with mutations at Glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor complex
|
Wu P.-C.; Hamaguchi N.; Yu Y.-S.; MING-CHING SHEN; Lin S.-W. |
| 臺大學術典藏 |
2021-05-25T06:36:02Z |
Discontinuous residues of factor IX constitute a surface for binding the anti-factor IX monoclonal antibody A-5
|
Chang Y.-J.; Wu H.-L.; Hsu Y.-C.; Hamaguchi N.; Shi G.-Y.; MING-CHING SHEN; Lin S.-W. |
| 臺大學術典藏 |
2021-05-25T06:35:55Z |
Characterisation of factor IX with a glycine-to-valine missense mutation at residue 190 in a patient with severe haemophilia B
|
Kao C.-Y.; Lin C.-N.; Yang Y.-L.; Hamaguchi N.; Yang S.-J.; MING-CHING SHEN; Kao J.-T.; Lin S.-W. |
| 臺大學術典藏 |
2021-01-06T03:39:09Z |
Characterisation of factor IX with a glycine-to-valine missense mutation at residue 190 in a patient with severe haemophilia B
|
Kao C.-Y.; Lin C.-N.; YUNG-LI YANG; Hamaguchi N.; Yang S.-J.; Shen M.-C.; Kao J.-T.; Lin S.-W. |
| 臺大學術典藏 |
2020-06-22T07:37:21Z |
Characterization of a factor IX variant with a glycine207 to glutamic acid mutation
|
Shu-Wha Lin;Lin C.-N.;Hamaguchi N.;Smith K.J.;Shen M.-C.; SHU-WHA LIN; Lin C.-N.; Hamaguchi N.; Smith K.J.; Shen M.-C. |
| 臺大學術典藏 |
2020-06-22T07:37:20Z |
Hemophilia B with mutations at Glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor complex
|
Wu P.-C.;Hamaguchi N.;Yu Y.-S.;Shen M.-C.;Shu-Wha Lin; Wu P.-C.; Hamaguchi N.; Yu Y.-S.; Shen M.-C.; SHU-WHA LIN |
| 臺大學術典藏 |
2020-06-22T07:37:20Z |
Engineered recombinant factor VII Q217 variants with altered inhibitor specificities
|
Chang Y.-J.;Hamaguchi N.;Chang S.-C.;Ruf W.;Shen M.-C.;Shu-Wha Lin; Chang Y.-J.; Hamaguchi N.; Chang S.-C.; Ruf W.; Shen M.-C.; SHU-WHA LIN |
| 臺大學術典藏 |
2020-06-22T07:37:17Z |
Identification of functionally important residues of the epidermal growth factor-2 domain of factor IX by alanine-scanning mutagenesis: Residues Asn89-Gly93 are critical for binding factor VIIIa
|
Chang Y.-J.;Wu H.-L.;Hamaguchi N.;Hsu Y.-C.;Shu-Wha Lin; Chang Y.-J.; Wu H.-L.; Hamaguchi N.; Hsu Y.-C.; SHU-WHA LIN |
| 臺大學術典藏 |
2020-06-22T07:37:17Z |
The distinct roles that Gln-192 and Glu-217 of factor IX play in selectivity for macromolecular substrates and inhibitors
|
Hsu Y.-C.;Hamaguchi N.;Chang Y.-J.;Shu-Wha Lin; Hsu Y.-C.; Hamaguchi N.; Chang Y.-J.; SHU-WHA LIN |
| 臺大學術典藏 |
2020-06-22T07:37:17Z |
Discontinuous residues of factor IX constitute a surface for binding the anti-factor IX monoclonal antibody A-5
|
Chang Y.-J.;Wu H.-L.;Hsu Y.-C.;Hamaguchi N.;Shi G.-Y.;Shen M.-C.;Shu-Wha Lin; Chang Y.-J.; Wu H.-L.; Hsu Y.-C.; Hamaguchi N.; Shi G.-Y.; Shen M.-C.; SHU-WHA LIN |
| 臺大學術典藏 |
2020-06-22T07:37:13Z |
Generation of a novel factor IX with augmented clotting activities in vitro and in vivo
|
Miao C.H.; Hamaguchi N.; Wu H.L.; Shi G.Y.; Liu Y.L.; High K.A.; SHU-WHA LIN; Lin C.N.;Kao C.Y.;Miao C.H.;Hamaguchi N.;Wu H.L.;Shi G.Y.;Liu Y.L.;High K.A.;Shu-Wha Lin; Lin C.N.; Kao C.Y. |
| 臺大學術典藏 |
2020-06-22T07:37:10Z |
Characterisation of factor IX with a glycine-to-valine missense mutation at residue 190 in a patient with severe haemophilia B
|
Kao C.-Y.;Lin C.-N.;Yang Y.-L.;Hamaguchi N.;Yang S.-J.;Shen M.-C.;Kao J.-T.;Shu-Wha Lin; Kao C.-Y.; Lin C.-N.; Yang Y.-L.; Hamaguchi N.; Yang S.-J.; Shen M.-C.; Kao J.-T.; SHU-WHA LIN |
| 臺大學術典藏 |
2011 |
Characterisation of factor IX with a glycine-to-valine missense mutation at residue 190 in a patient with severe haemophilia B
|
Lin S.-W.; JAU-TSUEN KAO; Shen M.-C.; Yang S.-J.; Kao C.-Y. ;Lin C.-N. ;Yang Y.-L. ;Hamaguchi N. ;Yang S.-J. ;Shen M.-C. ;Jau-Tsuen Kao ;Lin S.-W.; Kao C.-Y.; Lin C.-N.; Yang Y.-L.; Hamaguchi N. |
| 國立臺灣大學 |
2002-07 |
Identification of functionally important residues of the EGF-2 domain of factor IX by alanine scanning mutagenesis
|
Chang, YJ; Wu, HL; Hamaguchi, N; Hsu, YC; Lin, SW |
| 國立臺灣大學 |
2001-09 |
The distinct roles that Gln-192 and Glu-217 of factor IX play in selectivity for macromolecular substrates and inhibitor
|
Hsu, YC; Hamaguchi, N; Chang, YJ; Lin, SW |
| 國立臺灣大學 |
2000-10 |
Hemophilia B with mutations at glycine-48 of factor IX exhibited delayed activation by the factor VIIa-tissue factor com
|
Wu, PC; Hamaguchi, N; Yu, YS; Shen, MC; Lin, SW |
| 國立臺灣大學 |
1999-08 |
Engineered recombinant factor VII Q217 variants with altered inhibitor specificities
|
Chang, YJ; Hamaguchi, N; Chang, SC; Ruf, W; Shen, MC; Lin, SW |
| 國立臺灣大學 |
1993 |
Characterization of a Factor IX Variant with a Glycine207 to Glutamic Acid Mutation
|
林淑華; Lin, C. N.; Smith, K. J.; Hamaguchi, N.; Shen, M. C.; Lin, Shu-Wha; Lin, C. N.; Smith, K. J.; Hamaguchi, N.; Shen, M. C. |
